CDK7 inhibitor THZ1 inhibits MCL1 synthesis and drives cholangiocarcinoma apoptosis in combination with BCL2/BCL-XL inhibitor ABT-263

Tianlu Huang(Nanjing Drum Tower Hospital), Xiaoping Zou(Nanjing Medical University)
Cell Death and Disease
August 9, 2019
10.1038/s41419-019-1831-7
Cited by 42

Related Papers

BET protein inhibitor JQ1 downregulates chromatin accessibility and suppresses metastasis of gastric cancer via inactivating RUNX2/NID1 signaling
|Oncogenesis|2020|101
Metformin alleviates inflammation through suppressing FASN-dependent palmitoylation of Akt
|Cell Death and Disease|2021|76
Effects of proton pump inhibitors on reversing <br />multidrug resistance via downregulating V-ATPases/PI3K/Akt/mTOR/HIF-1α signaling pathway <br />through TSC1/2 complex and Rheb in human gastric adenocarcinoma cells in vitro and in vivo
|OncoTargets and Therapy|2018|55
Low nanomolar concentrations of Cucurbitacin-I induces G2/M phase arrest and apoptosis by perturbing redox homeostasis in gastric cancer cells in vitro and in vivo
|Cell Death and Disease|2016|47
Triptolide induces apoptotic cell death of human cholangiocarcinoma cells through inhibition of myeloid cell leukemia-1
|BMC Cancer|2014|39